OMCL
Omnicell·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 0
Consensus Rating "Strong Buy"
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OMCL
Omnicell, Inc.
A leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies
4220 North Freeway, Fort Worth, TX 76137
--
Omnicell, Inc., was incorporated in California in 1992 as Omnicell Technology Shares LLC and was re-incorporated in Delaware in 2001 as Omnicell Inc. The company is a leading provider of automated solutions for hospital medication and supply management. The company's medical automation solutions are designed to acquire, distribute and manage medicines and medical surgical supplies through healthcare facilities, improve patient safety, reduce wrong medication, improve workflow and increase work efficiency. Combined with its products and services, it enables healthcare facilities to provide comprehensive solutions to improve patient safety and operational efficiency.
Company Financials
EPS
OMCL has released its 2025 Q3 earnings. EPS was reported at 0.51, versus the expected 0.36, beating expectations. The chart below visualizes how OMCL has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
OMCL has released its 2025 Q3 earnings report, with revenue of 310.63M, reflecting a YoY change of 9.99%, and net profit of 5.46M, showing a YoY change of -36.71%. The Sankey diagram below clearly presents OMCL's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
